Mantra Venture Group Acquires Worldwide Exclusive License for Mixed Reactant Fuel Cell Technology
Posted on: Wednesday, 9 September 2009, 13:00 CDT
MRFC was designed by Professor Emeritus
Mantra's goal in signing this agreement is to carry the technology from its present development stages through to commercialization and to establish sub-licensing agreements thereafter. MRFC is currently in the worldwide patent application process.
Stay up to date with Mantra on Twitter: twitter.com/mantraenergy
About Mixed Reactant Fuel Cell (MRFC)
MRFC is a fuel cell with an unconventional architecture that eliminates the need for some operating features and components (such as the PEM) that are typically required in today's fuel cells. This simplification is expected to generate a significant economic advantage for the MRFC design. MRFC is currently in the critical stages of the patent application process, limiting the amount of technical information and specifications that can be released at this time. More information on the technology will be released shortly.
About Mantra Venture Group Ltd.
Mantra, through its group of sustainable energy, carbon reduction and consumer product subsidiaries, is active in the green technology marketplace with an innovative, multi-faceted approach focused on profitability through sustainability. By aggressively seeking out new technologies and innovating solutions for a cleaner earth for everyone, Mantra intends to provide a highly profitable and, more importantly, socially and environmentally responsible investment for its shareholders.
Mantra is a public company quoted on the OTC BB under the symbol MVTG and on the Frankfurt Stock Exchange under the symbol EDV 5MV.
Forward-Looking Statements:
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Mantra Venture Group's filings with the Securities and Exchange Commission which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
SOURCE Mantra Venture Group Ltd.
Source: PR Newswire
Related Articles
- Boeing and Leading Airlines Announce New Members Added to Sustainable Aviation Fuel Users Group
- Silicon Border Science Park to House Major Expansion for Q-Cells -Largest Manufacturer of Solar Cell Technology
- International Stem Cell Corporation Creates Human Stem Cell Lines That Can Eliminate Immune Rejection By Patients
- PrimeGen Biotech Presents Germ Cell Research at Abcam Stem Cell Conference
- Geron Announces Issuance of U.S. Patent for Production of Insulin Secreting Cells From Human Embryonic Stem Cells
- Geron Enters Into Research and Exclusive License Agreements With the University of Oxford for Derivation of Dendritic Cells From Human Embryonic Stem Cells
- Stem Cells Develop into Human Brain Cells in Mice: Study
- MultiCell Enters into a Joint Venture With Living Cell Technologies to Develop Adult Liver Cell Technologies for Drug Discovery, Protein Production and Therapeutic Clinical Applications
- Perturbation of NgTRF1 Expression Induces Apoptosis-Like Cell Death in Tobacco BY-2 Cells and Implicates NgTRF1 in the Control of Telomere Length and Stability
- `Splinter Cell' Looks Better Than Ever
User Comments (0)

RSS Feeds